177 related articles for article (PubMed ID: 21194431)
1. Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy.
Huo TI; Hsu CY; Huang YH; Su CW; Lin HC; Lee RC; Chiou YY; Chiang JH; Lee PC; Lee SD
BMC Gastroenterol; 2010 Dec; 10():146. PubMed ID: 21194431
[TBL] [Abstract][Full Text] [Related]
2. A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System.
Hsu CY; Huang YH; Hsia CY; Su CW; Lin HC; Loong CC; Chiou YY; Chiang JH; Lee PC; Huo TI; Lee SD
J Hepatol; 2010 Jul; 53(1):108-17. PubMed ID: 20451283
[TBL] [Abstract][Full Text] [Related]
3. The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.
Jiang T; Zhang XS; Pan F; Lyu SC; Wang J; Huang MX; He Q; Lang R
Medicine (Baltimore); 2021 Jul; 100(26):e26487. PubMed ID: 34190174
[TBL] [Abstract][Full Text] [Related]
4. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
[TBL] [Abstract][Full Text] [Related]
5. α-fetoprotein-to-total tumor volume ratio predicts post-operative tumor recurrence in hepatocellular carcinoma.
Lee YH; Hsu CY; Huang YH; Su CW; Lin HC; Hsia CY; Huo TI
J Gastrointest Surg; 2013 Apr; 17(4):730-8. PubMed ID: 23188220
[TBL] [Abstract][Full Text] [Related]
6. Total tumor volume predicts survival following liver resection in patients with hepatocellular carcinoma.
Li MX; Zhao H; Bi XY; Li ZY; Huang Z; Han Y; Zhou JG; Zhao JJ; Zhang YF; Wei WQ; Zhao DB; Cai JQ
Tumour Biol; 2016 Jul; 37(7):9301-10. PubMed ID: 26779628
[TBL] [Abstract][Full Text] [Related]
7. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
8. A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.
Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI
Dig Dis Sci; 2020 Feb; 65(2):658-667. PubMed ID: 31659612
[TBL] [Abstract][Full Text] [Related]
9. Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias?
Huo TI; Huang YH; Chiang JH; Wu JC; Lee PC; Chi CW; Lee SD
Scand J Gastroenterol; 2007 Apr; 42(4):485-92. PubMed ID: 17454859
[TBL] [Abstract][Full Text] [Related]
10. Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteria.
Lee YH; Hsia CY; Hsu CY; Huang YH; Lin HC; Huo TI
World J Surg; 2013 Jun; 37(6):1348-55. PubMed ID: 23467925
[TBL] [Abstract][Full Text] [Related]
11. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
[TBL] [Abstract][Full Text] [Related]
12. Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study.
Toro A; Ardiri A; Mannino M; Arcerito MC; Mannino G; Palermo F; Bertino G; Di Carlo I
BMC Surg; 2014 Jul; 14():40. PubMed ID: 24993566
[TBL] [Abstract][Full Text] [Related]
13. Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
Hsu CY; Huang YH; Chiou YY; Su CW; Lin HC; Lee RC; Chiang JH; Huo TI; Lee FY; Lee SD
Liver Transpl; 2011 May; 17(5):556-66. PubMed ID: 21506244
[TBL] [Abstract][Full Text] [Related]
14. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
Huo TI; Huang YH; Lui WY; Wu JC; Lee PC; Chang FY; Lee SD
Oncol Rep; 2004 Feb; 11(2):543-50. PubMed ID: 14719097
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
Wang Y; Chen Y; Ge N; Zhang L; Xie X; Zhang J; Chen R; Wang Y; Zhang B; Xia J; Gan Y; Ren Z; Ye S
Ann Surg Oncol; 2012 Oct; 19(11):3540-6. PubMed ID: 22532305
[TBL] [Abstract][Full Text] [Related]
16. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
[TBL] [Abstract][Full Text] [Related]
17. Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey.
Huo T; Huang YH; Wu JC; Chiang JH; Lee PC; Chang FY; Lee SD
Aliment Pharmacol Ther; 2004 Jun; 19(12):1301-8. PubMed ID: 15191512
[TBL] [Abstract][Full Text] [Related]
18. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
20. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
[Next] [New Search]